GLP-1 receptor agonists semaglutide and tirzepatide are associated with reduced risks of dementia, stroke, and mortality in adults with type 2 diabetes and obesity, new data show.

SHOPPING: Take charge of your health with help from Hims, the weight loss program that puts your specific needs front and ...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.

A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway ...

Mix one cup of unsweetened Greek yogurt, two tablespoons of chia seeds, and half a cup of mixed berries in a bowl. Let it sit ...

Tammy Slaton flaunts weight loss, Nick Carter's dance-driven slim-down and more celebrity weight loss revelations of 2025 ...

Newsweek spoke to some experts about whether the weight loss drug could have an impact on birth rates in America.

Modern weight loss medications represent a breakthrough, but they are most effective when combined with the right lifestyle strategies. Here's what that looks like.

Driven by expensive drugs, hospital stays and growing behavioral health needs, healthcare spending is expected to keep rising ...

The United States officially won't be involved in an enhanced pandemic global response enacted by the World Health ...

People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...